Building vaccine consensus

Article Abstract:

Klaus Stohr has described his experiences since he joined Novartis in February 2007 after leaving the World Health Organization (WHO). Stohr has given his views on pandemic threat and the necessity of developing and delivering vaccine to as many people as possible.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Watching Wolfson

Article Abstract:

The article discusses the achievements and goals of the Wolfson Institute for Biomedical Research (WIBR). The institute encourages and helps people with different interests to carry out their researches and publish papers of their works.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Entrepreneurs boldly break new ground: Viropharma - dreaming lean

Article Abstract:

Viropharma is one of the biggest pharmaceutical companies of the Greater Philadelphia region. It mainly focuses on developing new treatments for various serious infectious diseases, including hepatitis C and cytomegalovirus (CMV).

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: